These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37720905)

  • 1. Executive function deficits and medial temporal lobe atrophy in late-life depression and Alzheimer's disease: a comparative study.
    Chu C; Pan W; Ren Y; Mao P; Yang C; Liu C; Tang YL
    Front Psychiatry; 2023; 14():1243894. PubMed ID: 37720905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease].
    Liu SW; Li M; Zhu JT; Zhang YC; Wu YH; Liu CF; Hu H
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(35):2786-2792. PubMed ID: 36124351
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer's disease.
    Wan MD; Liu H; Liu XX; Zhang WW; Xiao XW; Zhang SZ; Jiang YL; Zhou H; Liao XX; Zhou YF; Tang BS; Wang JL; Guo JF; Jiao B; Shen L
    Front Aging Neurosci; 2022; 14():906519. PubMed ID: 35966797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of medial temporal lobe atrophy visual rating scale in detecting Alzheimer's disease: Preliminary study.
    Heo JH; Kim MK; Lee JH; Lee JH
    Ann Indian Acad Neurol; 2013 Jul; 16(3):384-7. PubMed ID: 24101822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic variability correlates with medial temporal lobe atrophy and decreased cognitive performance in patients with memory deficits.
    Zhang S; Wang A; Liu S; Liu H; Zhu W; Zhang Z
    Front Aging Neurosci; 2023; 15():1156908. PubMed ID: 37533764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of combined medial temporal atrophy and white matter lesions on the cognitive and emotional functions in Alzheimer's disease patients].
    Tokuchi R; Deguchi K; Yamashita T; Abe K
    Nihon Ronen Igakkai Zasshi; 2014; 51(4):342-9. PubMed ID: 25327368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of MR Visual Rating Scales in Major Forms of Dementia.
    Kaushik S; Vani K; Chumber S; Anand KS; Dhamija RK
    J Neurosci Rural Pract; 2021 Jan; 12(1):16-23. PubMed ID: 33531755
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country.
    Custodio N; Malaga M; Chambergo-Michilot D; Montesinos R; Moron E; Vences MA; Huilca JC; Lira D; Failoc-Rojas VE; Diaz MM
    Front Neurol; 2022; 13():962192. PubMed ID: 36119675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of depression on language function in individuals with Alzheimer's disease: a pre/post-treatment design.
    Yoon KH; Moon YS; Kim DH
    Ann Gen Psychiatry; 2023 Feb; 22(1):4. PubMed ID: 36737766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of semantic assessment in the differential diagnosis between late-life depression and Alzheimer's disease or amnestic mild cognitive impairment: systematic review and meta-analysis.
    Invernizzi S; Bodart A; Lefebvre L; Loureiro IS
    Eur J Ageing; 2023 Aug; 20(1):34. PubMed ID: 37563432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.
    Burton EJ; Barber R; Mukaetova-Ladinska EB; Robson J; Perry RH; Jaros E; Kalaria RN; O'Brien JT
    Brain; 2009 Jan; 132(Pt 1):195-203. PubMed ID: 19022858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum.
    Menne F; Schipke CG; Klostermann A; Fuentes-Casañ M; Freiesleben SD; Bauer C; Peters O
    J Alzheimers Dis; 2020; 78(2):819-826. PubMed ID: 33074230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing mental flexibility: neuroanatomical and neuropsychological correlates of the Trail Making Test in elderly people.
    Oosterman JM; Vogels RL; van Harten B; Gouw AA; Poggesi A; Scheltens P; Kessels RP; Scherder EJ
    Clin Neuropsychol; 2010 Feb; 24(2):203-19. PubMed ID: 20162494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    Molinder A; Ziegelitz D; Maier SE; Eckerström C
    BMC Neurol; 2021 Jul; 21(1):289. PubMed ID: 34301202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Cognitive Status and Atrophy Score in Alzheimer's Disease Among the Bangladeshi Population.
    Hakim M; Islam M; Hossain MA; Uddin MN; Baqui M; Hasan M; Islam MN; Mamun MT; Mamun AA; Ranjan R; Yusuf MA; Kawnayn G
    Cureus; 2024 Jul; 16(7):e65833. PubMed ID: 39219947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.